Journal
ACTA BIOCHIMICA ET BIOPHYSICA SINICA
Volume 46, Issue 1, Pages 15-21Publisher
SCIENCE PRESS
DOI: 10.1093/abbs/gmt123
Keywords
lung cancer; casticin; cancer stem cells; pAkt; therapeutic action
Categories
Funding
- Project of Scientific Research of Hunan Province the Administration Bureau of Traditional Chinese Medicine [201269]
- Youth Fund of Hunan Normal University [110637]
- Hunan province Science and Technology Project [2011FJ4144]
Ask authors/readers for more resources
A subpopulation of cancer stem cells is recognized as the cause of tumorigenesis and spreading. To investigate the effects of casticin (5,3'-dihydroxy-3,6,7,4'-tetramethoxyflavone), derived from Fructus Viticis Simplicifoliae, on lung cancer stem cells, we isolated and identified a subpopulation of lung cancer stem-like cells (LCSLCs) from non-small-cell lung carcinoma A549 cells with the features including self-renewal capacity and high invasiveness in vitro, elevated tumorigenic activity in vivo, and high expression of stem-ness markers CD133, CD44, and aldehyde dehydrogenase 1 (ALDH1), using serum-free suspension sphere-forming culture method. We then found that casticin could suppress the proliferation of LCSLCs in a concentration-dependent manner with an IC50 value of 0.4 mu mol/L, being much stronger than that in parental A549 cells. In addition, casticin could suppress the self-renewal and invasion of LCSLCs concomitant with decreased CD133, CD44, and ALDH1 protein expression and reduced MMP-9 activity. Further experiments showed that casticin suppressed self-renewal and invasion at least partly through down-regulation of Akt phosphorylation. In conclusion, casticin suppressed the characteristics of LCSLCs, suggesting that casticin may be a candidate compound for curing lung cancer via eliminating cancer stem cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available